Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
CNS Pharmaceuticals, Inc. (CNSP) had Cash Flow from Financial Activities of $20.98M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-2.50M |
|
-- |
|
-- |
|
$2.67M |
|
$-2.67M |
|
$0.17M |
|
$-2.50M |
|
$-2.50M |
|
$-2.50M |
|
$-2.50M |
|
$-2.50M |
|
$-2.50M |
|
$-2.67M |
|
$-2.67M |
|
10.61M |
|
10.61M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$18.05M |
|
$0.01M |
|
$0.01M |
|
$18.06M |
|
$2.36M |
|
-- |
|
-- |
|
$2.36M |
|
$15.71M |
|
$15.71M |
|
$15.71M |
|
1.48M |
|
| Cash Flow Statement Financials | |
$-10.96M |
|
$-0.01M |
|
|
Cash Flow from Financial Activities |
$20.98M |
$7.20M |
|
$17.21M |
|
$10.01M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.91% |
|
-15.91% |
|
-13.83% |
|
-15.91% |
|
$10.64 |
|
$-1.03 |
|
$-1.03 |
|